Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2025.

https://doi.org/10.1182/blood.V104.11.2025.2025

Published: 2004

Journal Articles

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Alexander Kohlmann, Ph.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 195.

https://doi.org/10.1182/blood.V104.11.195.195

Published: 2004

Journal Articles

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 4776.

https://doi.org/10.1182/blood.V104.11.4776.4776

Published: 2004

Journal Articles

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 2376.

https://doi.org/10.1182/blood.V104.11.2376.2376

Published: 2004

Journal Articles

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 400.

https://doi.org/10.1182/blood.V104.11.400.400

Published: 2004

Journal Articles

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Torsten Haferlach, M.D., Daniela Voskova, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D.

Blood (2004) 104 (11): 319.

https://doi.org/10.1182/blood.V104.11.319.319

Published: 2004

Journal Articles

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Wolfgang Kern, M.D., Alexander Kohlmann, Claudia Schoch, M.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.

Blood (2004) 104 (11): 993.

https://doi.org/10.1182/blood.V104.11.993.993

Published: 2004

Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Blood (2004) 104 (11): 871.

https://doi.org/10.1182/blood.V104.11.871.871

Published: 2004

NARROW

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only